Health product recall

Taro-Dipyridamole/ASA: impurity

Last updated

Summary

Product
Taro-Dipyridamole/ASA
Issue
Health products - Product quality
What to do

 

Consult your health care professional if you have any health concerns.

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot
Taro-Dipyridamole/ASA Taro-Dipyridamole/ASA DIN 02471051 Capsule (immediate and extended release) Acetylsalicylic acid 25mg/ Dipyridamole 200mg HAD3873A

Issue

An impurity is out of trend in the affected batch.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Wholesalers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Taro Pharmaceuticals Canada Inc.                                

130 East Drive,                                                 

Brampton, Ontario

L6T 1C1

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-74721